Aidea Pharma
68848813.832.22% ( +0.30 )
Aidea Pharma (688488)
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. It offers anti-HIV drugs and hu...
- Open
- 13.79
- High
- 14.40
- Low
- 13.50
- Prev. Close
- 13.53
- Volume
- 84.36K
- Turnover
- 118.78M
- Avg Price
- 14.08
- Bid/Ask Ratio
- --
- Amplitude
- 6.65%
- 52wk High
- 22.55
- Volume Ratio
- 0.50
- Turnover Ratio
- 2.00%
Aidea Pharma Analyst Rating
View MoreForecast & Rating
Sep 27, 2025Price forecast
¥20.8250.54%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- SCMP · Mar 26 at 12:31 AM
China’s Jiangsu Aidea eyes Hong Kong IPO as gateway to US, European Aids markets
- Wallstreetcn · Mar 19 at 01:30 AM
The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had significant declines
- Zhitong · Oct 27, 2025 at 05:09 AM
Aidea Pharma: Sodium Dolutegravir API receives approval for listing application
- Zhitong · Oct 10, 2025 at 07:13 PM
Aidea Pharma: The full text of the 96-week study on Fubangde® SPRINT was published in BMC Medicine
- Zhitong · Jul 27, 2025 at 02:53 AM
Aidea Pharma: Ainomit Tablets Obtains Drug Registration Certificate in Zanzibar
- Wallstreetcn · Jul 6, 2025 at 07:38 AM
New regulations for national HIV drug resistance research released, Aidea Pharma deeply involved
